If You Don’t Have COVID Vaccine Side Effects, Are You Still Protected?
Reactions reflect unique features of an individual’s immune system, not the strength of a response
Your Immune System Evolves to Fight Coronavirus Variants
Antibodies can change to counter new forms of the shape-shifting virus, research hints
Illustrating the history of pandemics
San Diego artist Patricia Pauchnick on how she assembled her illustration for the Immune Matters magazine article "How Pandemics End"
Analysis-In mutant variants, has the coronavirus shown its best tricks?
A clue to how some fast-growing tumors hide in plain sight
New LJI research could guide the development of more effective cancer immunotherapies
The Conrad Prebys Foundation grants more than $450,000 for studies into childhood cancer, cardiovascular disease
New funding will support high-risk, high-reward projects led by two early-career scientists
LJI team wins $500,000 XPRIZE for COVID-19 screening protocol
LA JOLLA—A team of scientists at La Jolla Institute for Immunology (LJI) has won the XPRIZE Rapid COVID Testing competition.
Erica Ollmann Saphire appointed president and CEO of La Jolla Institute for Immunology
Dr. Saphire will become La Jolla Institute’s fifth president when she formally begins her term on September 1, 2021
A cancer without a cause
Testing for breast and ovarian cancers has come a long way—but at-risk patients still fall through the cracks.
LJI research leads to promising combination therapy for type 1 diabetes
Phase 2 trial run by Novo Nordisk emphasizes the importance of translational research
Finding community at the UC San Diego-Petco Park Super Station
The UC San Diego Health-Petco Park Super Station is a huge operation—and a source of hope for many San Diegans
Immunologists take on vaccine FAQs
LJI releases new COVID-19 vaccine guide